Taipei, Taiwan - July 29, 2026 - ALPS Biotech Co., Ltd., an R&D-driven biotechnology company focused on biobased materials and advanced medical dressings, is advancing a next-generation Liquid Protective Gel powered by AL-BM002, its proprietary plant-derived adhesion material.
Designed as a practical alternative to conventional petrochemical-based liquid bandages, the AL-BM002 Liquid Protective Gel forms a clear, flexible film over the wound surface. The film is designed to help shield the area from dirt and external contaminants while maintaining breathability and freedom of movement.
Traditional liquid bandages may become stiff or brittle after application, particularly on joints and other high-movement areas. ALPS Biotech's formulation is engineered to create a lightweight, elastic barrier that moves naturally with the skin.
The gel is applied through a contact-free pump spray and forms a transparent protective layer in up to 30 seconds. Its water-resistant and sweat-resistant properties are designed to support daily activities, while the breathable film helps maintain a balanced wound environment. Depending on the application site and daily activity, the protective layer may remain in place for one to two days before gradually wearing away.
The alcohol-free formulation is also designed to provide a gentler application experience for sensitive skin. Once dry, the clear film is discreet on visible or frequently used areas such as the hands, fingertips, and behind the ears.
The AL-BM002 Liquid Protective Gel is being developed for a range of wound-protection needs, including minor cuts, abrasions, lacerations, minor burns, small post-surgical incisions, and skin care following selected laser or minimally invasive aesthetic procedures. The broader development program also explores potential applications in first-aid, emergency, and tactical medical settings.
ALPS Biotech is collaborating with the National Defense Medical University's biomedical sciences team to connect advanced material development with clinical insight and real-world care requirements. Announced in September 2025, the industry-academia partnership supports the development of next-generation liquid dressings for surgical and emergency-care environments.
ALPS Biotech's work on AL-BM002 reflects the company's wider commitment to combining medical innovation with environmental responsibility. By replacing conventional fossil-derived dressing materials with a plant-based, biodegradable alternative, the company aims to reduce dependence on petrochemical materials while supporting the global transition toward more sustainable healthcare solutions.
This approach brings together biobased material cultivation, manufacturing scale-up, clinical collaboration, and ESG management. It is part of ALPS Biotech's long-term strategy to develop medical technologies that are practical for healthcare professionals, comfortable for users, and more considerate of the environment.
Product features, intended uses, and availability may vary by market. Users should follow locally approved product labeling and seek professional medical advice when appropriate.
Founded in 2017, ALPS Biotech Co., Ltd. is a Taiwan-based, R&D-driven biotechnology company developing biobased materials, advanced medical dressings, and environmentally responsible healthcare solutions. Through industry-academia collaboration, clinical insight, and ESG-led innovation, ALPS Biotech is working to bring safe, effective, and sustainable technologies from research to real-world applications.
Add：12 F.-5, No. 50, Linsen N. Rd., Zhongshan Dist., Taipei City 104404, Taiwan (R.O.C.)
Tel:+886-2-27887626
Fax：+886-2-23788043
